https://www.selleckchem.com/pr....oducts/mps1-in-6-com
BACKGROUND Nausea seems underreported during pelvic radiotherapy. OBJECTIVE The aims of this study were to investigate if a 5-week recall measure of nausea covering the entire radiotherapy period was comparable with accumulated daily nausea measurements and to investigate if the measuring method affected potential difference in quality of life (QoL) between nauseated patients and patients free from nausea. METHODS This longitudinal methodology study covered 200 patients (mean age, 64 years; 84% women; 69% had gynecological
Tycka om
Kommentar
Dela med sig
